4
Changes in Ownership
Viridian Therapeutics, Inc.\DE Filed Acc 0000899243-22-004665
Chief Executive Officer sold 30,000 shares at an average $19.09 ($572,818)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Violin Jonathan Chief Executive Officer | 2022-02-01 | Sale | −16,751 | $19.55 | $327,482 | 614,154 | D |
| Violin Jonathan Chief Executive Officer | 2022-02-02 | Sale | −12,340 | $18.47 | $227,920 | 601,814 | D |
| Violin Jonathan Chief Executive Officer | 2022-02-03 | Sale | −909 | $19.16 | $17,416 | 600,905 | D |
| Derivatives | |||||||
| Violin Jonathan Chief Executive Officer | 2022-02-02 | Grant or award · Stock Option (Right to Buy) | +280,000 | 280,000 | D | ||
| Open-market sales · 30,000 sh · avg $19.09 · $572,818 | |||||||
Loading xslF345X03/doc4.xml…